Influence of Body Mass Index and Antibiotic Dose on the Risk of Surgical Site Infections in Pediatric Clean Orthopedic Surgery

被引:14
作者
Cies, Jeffrey J. [2 ,3 ]
Chan, Shannon [3 ]
Hossain, Jobayer [3 ]
Brenn, B. Randall [3 ,4 ]
Di Pentima, M. Cecilia [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Pediat,Med Ctr, Nashville, TN 37232 USA
[2] St Christophers Hosp Children, Philadelphia, PA 19133 USA
[3] Alfred I Dupont Hosp Children, Nemours Childrens Clin, Wilmington, DE USA
[4] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
关键词
NUTRITIONAL-STATUS; NOSOCOMIAL INFECTIONS; PROPHYLAXIS; OBESITY;
D O I
10.1089/sur.2011.096
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To evaluate body mass index (BMI) and antimicrobial dose as risk factors for surgical site infections in pediatric patients. Patients and Methods: Children between 2 and 19 years of age undergoing clean orthopedic procedures and receiving at least one dose of perioperative antibiotics (cefazolin, vancomycin, or clindamycin) were studied. The retrospective case-controlled study was conducted at the Alfred I. duPont Hospital for Children, a 180-bed tertiary-care academic pediatric hospital in Wilmington, DE. Data were collected from January 1, 2002, to December 31, 2005. Results: Underweight children had a higher risk for SSIs than overweight and normal-weight children. American Society of Anesthesiologists classes II and greater were associated with a greater risk of SSI. Longer procedures were also associated with a higher risk of SSI, specifically, duration of surgery >2 h. Children weighing 70 kg who received a standard dose of cefazolin (maximum of 1 g) had a higher risk of SSI caused by methicillin-sensitive Staphylococcus aureus (MSSA). Conclusions: Being underweight and undergoing an operation lasting >2 h created significant risks for SSI. Children weighing >= 70 kg receiving a standard 1-g dose of cefazolin had a greater risk of MSSA SSIs than children weighing <70 kg who received an appropriate weight-based dose of this antibiotic.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P1839
[2]   Vancomycin dosing in morbidly obese patients [J].
Bauer, LA ;
Black, DJ ;
Lill, JS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (08) :621-625
[3]   Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project [J].
Bratzler, DW ;
Houck, PM .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1706-1715
[4]   Nosocomial infections and obesity in surgical patients [J].
Cantürk, Z ;
Cantürk, NZ ;
Çetinarslan, B ;
Utkan, NZ ;
Tarkun, I .
OBESITY RESEARCH, 2003, 11 (06) :769-775
[5]  
Centers for Disease Control and Prevention, 2007, EST HEALTHC ASS INF
[6]   Effects of obesity on pharmacokinetics - Implications for drug therapy [J].
Cheymol, G .
CLINICAL PHARMACOKINETICS, 2000, 39 (03) :215-231
[7]  
CHOBAN PS, 1995, AM SURGEON, V61, P1001
[8]   NUTRITIONAL-STATUS - IMPORTANCE IN PREDICTING WOUND-HEALING AFTER AMPUTATION [J].
DICKHAUT, SC ;
DELEE, JC ;
PAGE, CP .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1984, 66A (01) :71-75
[9]   Nutritional status and wound healing in open fractures of the lower limb [J].
Dwyer, AJ ;
John, B ;
Mam, MK ;
Antony, P ;
Abraham, R ;
Joshi, M .
INTERNATIONAL ORTHOPAEDICS, 2005, 29 (04) :251-254
[10]   Perioperative antibiotic prophylaxis in the gastric bypass patient: Do we achieve therapeutic levels? [J].
Edmiston, CE ;
Krepel, C ;
Kelly, H ;
Larson, J ;
Andris, D ;
Hennen, C ;
Nakeeb, A ;
Wallace, JR .
SURGERY, 2004, 136 (04) :738-745